Drug intelligence / Profile preview

shuanghuang shengbai

Development stage
Unknown
Lead developer
Changshu Leiyunshang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Shuanghuang Shengbai is a traditional Chinese medicine (TCM) herbal formulation primarily used to prevent and treat myelosuppression (bone marrow suppression) caused by chemotherapy in cancer patients. It is available as granules or oral liquid. The main bioactive ingredients are Astragaloside IV and saponins from Rhizoma Polygonati. Mechanistically, it promotes the proliferation of bone marrow hematopoietic stem cells and increases white blood cell counts by modulating specific microRNAs (such as upregulating miR-106b*, miR-144, miR-669k* and downregulating miR-142-3p, miR-210, and miR-223). Additionally, it inhibits the proliferation of lung cancer stem cells via other microRNA pathways. Clinical studies have shown that Shuanghuang Shengbai can reduce rates of neutropenia and other forms of myelosuppression during chemotherapy without promoting tumor growth[1][2][3][4][7].

Brand names
Shuanghuang ShengbaiShuanghuang Shengbai GranuleShuanghuang Shengbai Oral Liquid
Other names
双黄升白SSGSHSBG

Beyond the preview

Go deeper on shuanghuang shengbai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shuanghuang shengbai.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call